Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

CUSIP: N69605108

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
65,632,680
Total 13F shares
40,745,703
Share change
+11,678,601
Total reported value
$1,142,917,292
Price per share
$28.05
Number of holders
36
Value change
+$327,949,428
Number of buys
30
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q4 2023

As of 31 Dec 2023, Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,745,703 shares. The largest 10 holders included GENERAL ATLANTIC, L.P., FMR LLC, venBio Partners LLC, Foresite Capital Management IV, LLC, Bain Capital Life Sciences Investors, LLC, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Cormorant Asset Management, LP, Novo Holdings A/S, and EcoR1 Capital, LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.